Healthy Skepticism Library item: 6669

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: report

Pharmaceutical Advertising Advisory Board
Position paper on direct-to-consumer (DTC) prescription drug promotional materials
: Pharmaceutical Advertising Advisory Board 1996 May 15
www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/consult/wkshd2ca.zip

Abstract:

The current regulatory restrictions which limit direct-to-consumer advertising in Canada are, in the view of the Pharmaceutical Advertising Advisory Board, unsustainable in the long term for a variety of reasons: advertising from cross-border media; availability of other unregulated information on sources such as the Internet; world-wide trend to consumer involvement in health; and imbalance resulting from the narrow scope of the current restrictions. If the use of direct-to-consumer advertising is permitted, material should be subject to review and preclearance.

Keywords:
*policy statement & guideline/Canada/direct-to-consumer advertising/DTCA/preclearance of advertisements/regulation of promotion/ATTITUDES REGARDING PROMOTION: REGULATORS AND GOVERNMENT/EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING/REGULATION, CODES, GUIDELINES: AUTONOMOUS BODIES